Chakmeedaj Sethanandha, M.D.

Division : Nuclear Medicine, Department of Radiology

Specialty groups : Nuclear Medicine

Languages : Thai, English

Field of interests : General Nuclear Medicine, PET/CT imaging, Nuclear Neurology

Education
Year
2015-2016
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA
Fellowship in Nuclear Neurology Los Angeles, CA 90095, United States
2007-2010
Siriraj Hospital, Faculty of Medicine, Mahidol University Residency in Nuclear Medicine Bangkok, Thailand
2005-2006
Chachoengsao General Hospital Internship Chachoengsao, Thailand
1999-2005
Faculty of Medicine, Rangsit University Doctor of Medicine, March 2005 Bangkok, Thailand
Certifications
Year
2016
Fellowship in PET/CT and Nuclear Neurology UCLA, CA, United States
2010
Thai Board of Nuclear Medicine The Medical Council of Thailand
2008
Graduate Diploma Program in Clinical Sciences in Radiology Mahidol University, Bangkok, Thailand
2008
Medical Radiation Physics and Radiobiology The Radiological Society of Thailand
Awards and honors
Year
2014
IAEA/RCA Regional Training Course
2011
Endeavour Executive Awards
Professional memberships
Year
Present
The Medical Council of Thailand
Present
The Medical Association of Thailand
Present
Royal College of Radiologists of Thailand
Present
Nuclear Medicine Society of Thailand
Present
The Dementia Association of Thailand
Recent publications
  1. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, et al. Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer’s disease. Ann Nucl Med. 2020;34(5):337-48.
  2. Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, et al. Changes in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer’s disease: Results of a randomized, double-blinded, pilot study. Exp Gerontol. 2018;111:118-21.
  3. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, et al. Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer’s disease: first-hand experience in Thailand. Nucl Med Commun. 2018;39(2):186-92.
  4. Sriprapaporn J, Sethanandha C, Yingsa-nga T, Komoltri C, Thongpraparn T, Harnnanthawiwai C. Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer. J Med Assoc Thai. 2015;98(6):596-605.